{
    "title": "Shire seen having to sweeten $30 billion offer to win Baxalta",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3188576/Shire-seen-having-sweeten-30-billion-offer-win-Baxalta.html",
    "date": "2015-08-05",
    "keywords": [
        "offer",
        "market",
        "shire",
        "baxalta",
        "haemophilia",
        "deal",
        "gene",
        "gmt",
        "august",
        "drugmaker",
        "risk",
        "board",
        "value",
        "mab",
        "therapy",
        "email",
        "kumar",
        "ben",
        "hirschlerlondon",
        "executive",
        "deeper",
        "pocket",
        "company",
        "doctor",
        "massachusetts",
        "option",
        "run",
        "premium",
        "battle",
        "transaction",
        "science",
        "revenuewith",
        "poison",
        "pill",
        "defence",
        "hardtoreplace",
        "block",
        "way",
        "forwardand",
        "allshare",
        "share",
        "businessyou",
        "increase",
        "fund",
        "manager",
        "stake",
        "youve",
        "potential",
        "somebody",
        "move",
        "berenberg",
        "bank",
        "baxaltaornskov",
        "tacticsone",
        "person",
        "information",
        "access",
        "valuationornskov",
        "kilsby",
        "credit",
        "suisse",
        "banker",
        "antitakeover",
        "baxter",
        "rationale",
        "logic",
        "leader",
        "tax",
        "domicilebut",
        "feiba",
        "advate",
        "sell",
        "frontsroche",
        "antibody",
        "treatment",
        "longlasting",
        "curesbaxalta",
        "foothold",
        "space",
        "programme",
        "adoption",
        "sharethe",
        "gap",
        "strategy",
        "change",
        "bernstein",
        "note",
        "work",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}